(Updated - August 19, 2026 7:00 AM EDT)

Wedbush analyst David Nierengarten initiates coverage on Aktis Oncology (NASDAQ: AKTS) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Hot Comments Hot New Coverage New Coverage